Collegium Pharmaceutical Inc (COLL)
R&D Expense Growth
0.00%
Quarterly · Period ending:
COLL R&D Expense Growth
Latest reported0.00%period ending
Latest reported0.00%period ending
COLL Quarterly R&D Growth (QoQ) (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
COLL r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 147.5451% | |
| 10.9655% | |
| -58.1167% | |
| 18.157% | |
| 18.5275% | |
| 15.4601% | |
| -14.1195% | |
| -6.4891% | |
| 11.176% | |
| -3.7334% | |
| 1.3013% | |
| -17.8142% | |
| 33.0369% | |
| 17.9339% | |
| -14.7519% | |
| -1.3668% | |
| 3.3728% | |
| 6.0416% | |
| -5.0482% | |
| 2.3005% | |
| -36.0552% | |
| 2.3663% | |
| -24.3432% | |
| 5.8838% | |
| 165.3168% | |
| -54.4074% | |
| 104.6313% | |
| 13.564% | |
| -37.3645% | |
| -60.3472% | |
| 63.1978% | |
| 9.0548% | |
| 0% |